Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

CorMedix (CRMD) Shares Issued (2016 - 2025)

CorMedix has reported Shares Issued over the past 11 years, most recently at $79.6 million for Q4 2025.

Quarterly results put Shares Issued at $79.6 million for Q4 2025, up 4307.4% from a year ago — trailing twelve months through Dec 2025 was $82.4 million (up 764.77% YoY), and the annual figure for FY2025 was $82.4 million, up 2745566.67%.
Shares Issued reached $79.6 million in Q4 2025 per CRMD's latest filing, up from $1.3 million in the prior quarter.
Across five years, Shares Issued topped out at $79.6 million in Q4 2025 and bottomed at -$41.3 million in Q3 2021.
Median Shares Issued over the past 5 years was $1.7 million (2024), compared with a mean of $6.6 million.
The largest annual shift saw Shares Issued soared 63440.6% in 2022 before it plummeted 169.31% in 2023.
Over 5 years, Shares Issued stood at -$27851.0 in 2021, then skyrocketed by 63440.6% to $17.6 million in 2022, then tumbled by 169.31% to -$12.2 million in 2023, then soared by 84.53% to -$1.9 million in 2024, then soared by 4307.4% to $79.6 million in 2025.
Business Quant data shows Shares Issued for CRMD at $79.6 million in Q4 2025, $1.3 million in Q3 2025, and -$5.3 million in Q2 2025.